Remco Nagel

5.8k citations

26 papers · 4.4k indexed · 4 hit papers · h-index 18

Molecular Biology top 2%
Cancer Research top 0.5%
Oncology top 5%
Surgery top 10%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Reuven Agami Carlos le Sage Mariëtte Schrier P. Mathijs Voorhoeve David A. Egan Anton Berns Ekaterina A. Semenova Joachim A.F. Oude Vrielink
Topics: RNA modifications and cancer (9 papers)MicroRNA in disease regulation (8 papers)Epigenetics and DNA Methylation (4 papers)
Cited by: Cancer Research Molecular Biology Aging
Journals: Cell Nucleic Acids Research Genes & Development
Partner nations: Netherlands Italy Israel

In The Last Decade

Remco Nagel

26 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors

2006 1.0k citations P. Mathijs Voorhoeve, Carlos le Sage et al. Cell profile →
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

2008 800 citations Qihong Huang, Kiranmai Gumireddy et al. Nature Cell Biology profile →
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

2007 651 citations Carlos le Sage, Remco Nagel et al. The EMBO Journal profile →
RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

2007 591 citations Martijn Kedde, Bijan Boldajipour et al. Cell profile →

Peers

Countries citing papers authored by Remco Nagel

Since Specialization

Citations

This map shows the geographic impact of Remco Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remco Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remco Nagel more than expected).

Fields of papers citing papers by Remco Nagel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remco Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remco Nagel. The network helps show where Remco Nagel may publish in the future.

Co-authorship network of co-authors of Remco Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of Remco Nagel. A scholar is included among the top collaborators of Remco Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remco Nagel. Remco Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer 2024 ·Nucleic Acids Research ·(unknown),Remco Nagel,(unknown),Onno B. Bleijerveld,(unknown),(unknown),(unknown),Natalie Proost,Marieke van de Ven,(unknown),(unknown),Abhijeet Pataskar,Daniel S. Peeper,Julien Champagne,Reuven Agami	2
2	Boosting Antitumor Immunity with an Expanded Neoepitope Landscape 2022 ·Cancer Research ·Remco Nagel,Abhijeet Pataskar,Julien Champagne,Reuven Agami	9
3	Oncogene-dependent sloppiness in mRNA translation 2021 ·Molecular Cell ·Julien Champagne,Abhijeet Pataskar,(unknown),Remco Nagel,(unknown),(unknown),Juliana C.N. Kenski,Onno B. Bleijerveld,Esther A. Zaal,Celia R. Berkers,Maarten Altelaar,Daniel S. Peeper,William J. Faller,Reuven Agami	30
4	Proteomic patterns associated with response to breast cancer neoadjuvant treatment 2020 ·Molecular Systems Biology ·Anjana Shenoy,Nishanth Belugali Nataraj,Gili Perry,Fabricio Loayza‐Puch,Remco Nagel,(unknown),(unknown),Noa Bossel Ben‐Moshe,(unknown),Iris Barshack,Bella Kaufman,Reuven Agami,Yosef Yarden,Maya Dadiani,Tamar Geiger	38
5	Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin 2019 ·Molecular Cancer Therapeutics ·Remco Nagel,(unknown),Nanne Aben,Natalie Proost,Marieke van de Ven,Jan van der Vliet,Miranda Cozijnsen,(unknown),Lodewyk F.A. Wessels,Anton Berns	25
6	SLC 1A3 contributes to L‐asparaginase resistance in solid tumors 2019 ·The EMBO Journal ·Jianhui Sun,Remco Nagel,Esther A. Zaal,Alejandro P. Ugalde,Ruiqi Han,Natalie Proost,Ji‐Ying Song,Abhijeet Pataskar,Artur M Burylo,Haigen Fu,Gerrit J. Poelarends,Marieke van de Ven,Olaf van Tellingen,Celia R. Berkers,Reuven Agami	48
7	CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells 2018 ·Cancer Letters ·Rui Lopes,Gözde Korkmaz,Sonia Aristín Revilla,(unknown),Remco Nagel,Lars Custers,Yongsoo Kim,Pieter C. Van Breugel,Wilbert Zwart,(unknown),(unknown),Ran Elkon,Reuven Agami	6
8	Drugging the addict: non‐oncogene addiction as a target for cancer therapy 2016 ·EMBO Reports ·Remco Nagel,Ekaterina A. Semenova,Anton Berns	108
9	Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC 2015 ·Molecular Cancer Therapeutics ·Remco Nagel,Marijke Stigter‐van Walsum,Marijke Buijze,Jaap van den Berg,(unknown),(unknown),Sander R. Piersma,Thang V. Pham,Connie R. Jiménez,Victor W. van Beusechem,Ruud H. Brakenhoff	32
10	Origins, genetic landscape, and emerging therapies of small cell lung cancer 2015 ·Genes & Development ·Ekaterina A. Semenova,Remco Nagel,Anton Berns	176
11	Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer 2013 ·Clinical Cancer Research ·Sanne R. Martens‐de Kemp,Remco Nagel,Marijke Stigter‐van Walsum,(unknown),Victor W. van Beusechem,Boudewijn J.M. Braakhuis,Ruud H. Brakenhoff	68
12	Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines 2013 ·Oral Oncology ·Remco Nagel,Sanne R. Martens‐de Kemp,Marijke Buijze,(unknown),Boudewijn J.M. Braakhuis,Ruud H. Brakenhoff	62
13	The miRNA‐192/194 cluster regulates the Period gene family and the circadian clock 2009 ·FEBS Journal ·Remco Nagel,Linda Clijsters,Reuven Agami	104
14	Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer 2008 ·Cancer Research ·Remco Nagel,Carlos le Sage,Begoña Diosdado,Maike van der Waal,Joachim A.F. Oude Vrielink,Anne S. Bolijn,Gerrit A. Meijer,Reuven Agami	392
15	The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis 2008 ·Cancer Research ·Qihong Huang,Kiranmai Gumireddy,Mariëtte Schrier,Carlos le Sage,Remco Nagel,Suresh Nair,David Egan,An‐Ping Li,Guanghua Huang,Andres J. Klein–Szanto,(unknown),Dionyssios Katsaros,George Coukos,Lin Zhang,Ellen Puré,Reuven Agami	1
16	The microRNAs miR-373 and miR-520c promote tumour invasion and metastasisbreakdown → 2008 ·Nature Cell Biology ·Qihong Huang,Kiranmai Gumireddy,Mariëtte Schrier,Carlos le Sage,Remco Nagel,Suresh Nair,David A. Egan,An‐Ping Li,Guanghua Huang,Andres J. Klein–Szanto,Phyllis A. Gimotty,Dionyssios Katsaros,George Coukos,Lin Zhang,Ellen Puré,Reuven Agami	800
17	RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNAbreakdown → 2007 ·Cell ·Martijn Kedde,(unknown),Bijan Boldajipour,Joachim A.F. Oude Vrielink,Krasimir Slanchev,Carlos le Sage,Remco Nagel,P. Mathijs Voorhoeve,(unknown),Ulf Andersson Ørom,Anders H. Lund,Anastassis Perrakis,Erez Raz,Reuven Agami	591
18	Diverse Ways to Control p27Kip1 Function: miRNAs Come into Play 2007 ·Cell Cycle ·Carlos le Sage,Remco Nagel,Reuven Agami	50
19	Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferationbreakdown → 2007 ·The EMBO Journal ·Carlos le Sage,Remco Nagel,David A. Egan,Mariëtte Schrier,Elly Mesman,Annunziato Mangiola,(unknown),Giulio Maira,Neri Mercatelli,Silvia Anna Ciafrè,Maria Giulia Farace,Reuven Agami	651
20	A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumorsbreakdown → 2006 ·Cell ·P. Mathijs Voorhoeve,Carlos le Sage,Mariëtte Schrier,Ad Gillis,Hans Stoop,Remco Nagel,Ying Poi Liu,(unknown),Jarno Drost,Alexander Griekspoor,Eitan Zlotorynski,Norikazu Yabuta,Gabriella De Vita,Hiroshi Nojima,Leendert H. J. Looijenga,Reuven Agami	1023

About Remco Nagel

Remco Nagel is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 26 papers that have together received 4.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (2.8k citations), Molecular Biology (3.5k citations) and Aging (43 citations). Remco Nagel has collaborated with scholars based in Netherlands, Italy and Israel. Frequent co-authors include Reuven Agami, Carlos le Sage, Mariëtte Schrier, P. Mathijs Voorhoeve, David A. Egan, Anton Berns, Ekaterina A. Semenova, Joachim A.F. Oude Vrielink, Alexander Griekspoor and Hiroshi Nojima. Their work appears in journals such as Cell, Nucleic Acids Research and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact